Annual Report

Overview

The report describes continued advancement of the company's predictive diagnostic pipeline, including PromarkerD, PromarkerEndo and PromarkerEso. PromarkerD gained a French distribution appointment and a US Medicare reimbursement price, while PromarkerEndo achieved independent-cohort validation and signed an agreement with Oxford for further validation. The company also retained ISO 13485 manufacturing certification and reported a gender-balanced workforce in its ESG section.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 30 June 2024
Publication date: 23 August 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services